The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
18F-fluorocholine positron emission tomography/computed tomography for early outcome prediction in metastatic castration-resistant prostate cancer patients treated with enzalutamide: A proof-of-principle study.
Ugo De Giorgi
No relevant relationships to disclose
Paola Caroli
No relevant relationships to disclose
Emanuela Scarpi
No relevant relationships to disclose
Vincenza Conteduca
No relevant relationships to disclose
Salvatore Luca Burgio
No relevant relationships to disclose
Cecilia Menna
No relevant relationships to disclose
Emanuela Bianchi
No relevant relationships to disclose
Lorena Rossi
No relevant relationships to disclose
Giovanni Paganelli
No relevant relationships to disclose
Dino Amadori
No relevant relationships to disclose
Federica Matteucci
No relevant relationships to disclose